AI RESEARCH
A Specialized Importance-Aware Quantum Convolutional Neural Network with Ring-Topology (IA-QCNN) for MGMT Promoter Methylation Prediction in Glioblastoma
arXiv CS.LG
•
ArXi:2604.22877v1 Announce Type: cross GBM is a highly aggressive primary malignancy in adults, necessitating personalized therapeutic strategies due to its inherent molecular heterogeneity. MGMT promoter methylation is a pivotal prognostic biomarker for anticipating response to temozolomide-based chemotherapy. Although various AI frameworks have been developed for non-invasive MGMT prediction, spatial heterogeneity of methylation status and the high-dimensional and correlated nature of MRI data frequently constrain discriminative feature learning and generalizability of classical models.